ES307299A1 - Procedimiento para la preparacion de 6,7-benzomorfanos sustituidos. - Google Patents

Procedimiento para la preparacion de 6,7-benzomorfanos sustituidos.

Info

Publication number
ES307299A1
ES307299A1 ES0307299A ES307299A ES307299A1 ES 307299 A1 ES307299 A1 ES 307299A1 ES 0307299 A ES0307299 A ES 0307299A ES 307299 A ES307299 A ES 307299A ES 307299 A1 ES307299 A1 ES 307299A1
Authority
ES
Spain
Prior art keywords
compound
general formula
radical
group
radicals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0307299A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JR Geigy AG filed Critical JR Geigy AG
Publication of ES307299A1 publication Critical patent/ES307299A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Discharge Lamp (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES0307299A 1963-12-20 1964-12-19 Procedimiento para la preparacion de 6,7-benzomorfanos sustituidos. Expired ES307299A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33229663A 1963-12-20 1963-12-20

Publications (1)

Publication Number Publication Date
ES307299A1 true ES307299A1 (es) 1965-05-16

Family

ID=23297612

Family Applications (4)

Application Number Title Priority Date Filing Date
ES0307300A Expired ES307300A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6,7-benzomorfanos sustituidos.
ES0307302A Expired ES307302A1 (es) 1963-12-20 1964-12-19 Procedimiento para preparar nuevos 6,7-benzomorfanos sustituidos.
ES0307301A Expired ES307301A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6, 7-benzomorfanos sustituidos
ES0307299A Expired ES307299A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de 6,7-benzomorfanos sustituidos.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES0307300A Expired ES307300A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6,7-benzomorfanos sustituidos.
ES0307302A Expired ES307302A1 (es) 1963-12-20 1964-12-19 Procedimiento para preparar nuevos 6,7-benzomorfanos sustituidos.
ES0307301A Expired ES307301A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6, 7-benzomorfanos sustituidos

Country Status (12)

Country Link
AT (4) AT249277B (da)
BE (2) BE657405A (da)
CH (7) CH449643A (da)
DE (2) DE1445853A1 (da)
DK (4) DK108497C (da)
ES (4) ES307300A1 (da)
FR (2) FR4345M (da)
GB (2) GB1077711A (da)
IL (2) IL22642A (da)
NL (3) NL6414820A (da)
NO (2) NO119273B (da)
SE (2) SE322779B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP2987788A1 (en) 2002-05-17 2016-02-24 Taiwanj Pharmaceuticals Co., Ltd. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP5486928B2 (ja) 2007-02-26 2014-05-07 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1のサイクリックウレアおよびカルバメートインヒビター
JP5451611B2 (ja) 2007-07-26 2014-03-26 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1のサイクリックインヒビター
AR069207A1 (es) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
CA2704628C (en) 2007-11-16 2016-11-29 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
WO2009075835A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceutical, Inc CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
JP5490020B2 (ja) 2008-01-24 2014-05-14 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状カルバゼート及びセミカルバジドインヒビター
JP5734666B2 (ja) 2008-02-11 2015-06-17 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の1,3−オキサアゼパン−2−オン及び1,3−ジアゼパン−2−オン阻害剤
US20110028445A1 (en) * 2008-02-12 2011-02-03 Boehringer Ingelheim International Gmbh Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
US8598160B2 (en) 2008-02-15 2013-12-03 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
JP5538365B2 (ja) 2008-05-01 2014-07-02 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
US8242111B2 (en) 2008-05-01 2012-08-14 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
CL2009001058A1 (es) 2008-05-01 2010-09-10 Vitae Pharmaceuticals Inc Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras.
PL2300461T3 (pl) 2008-05-01 2013-09-30 Vitae Pharmaceuticals Inc Cykliczne inhibitory dehydrogenazy 11beta-hydroksysteroidów 1
US8765780B2 (en) 2008-05-13 2014-07-01 Boehringer Ingelheim International Gmbh Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
CA2729998A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2687525B1 (en) 2008-07-25 2015-09-23 Boehringer Ingelheim International GmbH Cyclic inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
WO2010046445A2 (en) 2008-10-23 2010-04-29 Boehringer Ingelheim International Gmbh Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
WO2010089303A1 (en) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
WO2010139673A1 (en) 2009-06-02 2010-12-09 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
EP2448928B1 (en) 2009-07-01 2014-08-13 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
AR078887A1 (es) 2009-11-06 2011-12-07 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina y composiciones farmaceuticas que los contienen.
JP5860042B2 (ja) 2010-06-16 2016-02-16 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 置換5、6及び7員複素環、そのような化合物を含有する医薬及びそれらの使用
WO2011161128A1 (en) 2010-06-25 2011-12-29 Boehringer Ingelheim International Gmbh Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
WO2012059416A1 (en) 2010-11-02 2012-05-10 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
JP2014524438A (ja) 2011-08-17 2014-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング インデノピリジン誘導体

Also Published As

Publication number Publication date
DE1445854A1 (de) 1968-12-05
AT249277B (de) 1966-09-12
ES307301A1 (es) 1965-05-16
GB1092394A (en) 1967-11-22
DK108495C (da) 1967-12-27
CH448118A (de) 1967-12-15
NL6414820A (da) 1965-06-21
DK108496C (da) 1967-12-27
ES307302A1 (es) 1965-05-16
DK108497C (da) 1967-12-27
CH449640A (de) 1968-01-15
SE305657B (da) 1968-11-04
AT253687B (de) 1967-04-25
GB1077711A (en) 1967-08-02
NO119274B (da) 1970-04-27
DK106552C (da) 1967-02-20
SE322779B (da) 1970-04-20
BE657405A (da) 1965-06-21
IL22643A (en) 1968-07-25
IL22642A (en) 1968-07-25
AT249276B (de) 1966-09-12
NO119273B (da) 1970-04-27
NL127995C (da)
BE657406A (da) 1965-06-21
NL6414821A (da) 1965-06-21
CH449639A (de) 1968-01-15
FR4345M (da) 1966-08-16
CH449642A (de) 1968-01-15
DE1445853A1 (de) 1968-12-05
CH449643A (de) 1968-01-15
FR4346M (da) 1966-08-16
CH449641A (de) 1968-01-15
AT261126B (de) 1968-04-10
CH446371A (de) 1967-11-15
ES307300A1 (es) 1965-05-01

Similar Documents

Publication Publication Date Title
ES307299A1 (es) Procedimiento para la preparacion de 6,7-benzomorfanos sustituidos.
ES385302A1 (es) Procedimiento para la obtencion de derivados trisubstitui- dos de etilendiamina.
ES330368A1 (es) Procedimiento para preparar derivados n-alcohilamino-alcohilicos de espirotetralinosuccinimidas y sus sales.
ES402627A1 (es) Procedimiento para la obtencion de derivados del acido prostanoico.
GB961037A (en) Pyrazolones and processes for their preparation
GB1049123A (en) Substituted aralkyl piperazines and homopiperazines
GB851311A (en) Morpholine compounds and their production
ES298013A1 (es) Procedimiento depreparación de nuevos derivados de la quinoleína
ES274334A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1,4-benzodioxano
ES301710A1 (es) Procedimiento para la preparación de nuevas 1,2-diaril-4-alquil-3,5-dioxo-pirazolidinas
ES315014A1 (es) Procedimientos para la preparacion de una amidina o una sal de adicion de acido correspondiente.
ES360031A1 (es) Procedimiento para la preparacion de 1,2,4-oxadiazoles iso-meros.
ES296118A1 (es) Procedimiento para la producciën de nuevos compuestos heterociclicos
ES416013A1 (es) Un procedimiento de preparacion de nuevas sales de indami- nas.
ES306706A1 (es) Procedimiento para la obtencion de derivados de la urea
ES486629A1 (es) Procedimiento para la obtencion de derivados tiadiazolicos
ES323653A1 (es) Un procedimiento para preparar compuestos fitotoxicos.
ES325110A1 (es) Procedimiento para la preparacion de derivados 3-hidroxi- y 3-mercapto-1,2,8,9-tetraazafenalenos.
ES277887A1 (es) Procedimiento para la preparación de nuevos compuestos n-heterocíclicos
ES280821A1 (es) Procedimiento para la obtencion de nuevas benzolsulfonil-semicarbacidas
ES305739A1 (es) Procedimiento para la preparacion de nuevos 5-fenil-6,7-benzomorfanos sustituidos.
ES226163A1 (es) UN PROCEDIMIENTO PARA LA PREPARACIoN DE DERIVADOS DE PIPERIDINA
ES271999A1 (es) Procedimiento para la preparación de nuevos derivados de cumarina
ES302769A1 (es) Procedimiento para la producción de compuestos heterocíclicos
ES252657A1 (es) Procedimiento para la obtenciën de derivados de difenilmetano substituidos por radicales basicos